FDA
approval
· 2025-04-16
FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approves Camber Pharmaceuticals' Abacavir and Lamivudine as an original application for the treatment of HIV-1 infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)